Abstract P1-15-01: A randomized phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally-advanced hormone-receptor-positive breast cancer: First results

2013 ◽  
Author(s):  
N Quenel-Tueux ◽  
F Dalenc ◽  
T Bachelot ◽  
M Pulido ◽  
H Bonnefoi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Hormone Receptor Positive ◽  
Randomized Phase Ii ◽  
First Results ◽  
Positive Breast Cancer

scholarly journals Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–positive Breast Cancer

2021 ◽  
Vol 27 (5) ◽  
pp. 1582-1582
Author(s):  
Sara M. Tolaney ◽  
Solmaz Sahebjam ◽  
Emilie Le Rhun ◽  
Thomas Bachelot ◽  
Peter Kabos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastases ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Hormone Receptor Positive ◽  
Positive Breast Cancer

scholarly journals A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer

2020 ◽  
Vol 26 (20) ◽  
pp. 5310-5319 ◽  
Author(s):  
Sara M. Tolaney ◽  
Solmaz Sahebjam ◽  
Emilie Le Rhun ◽  
Thomas Bachelot ◽  
Peter Kabos ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Brain Metastases ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Hormone Receptor Positive ◽  
Positive Breast Cancer

scholarly journals A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer

2014 ◽  
Vol 3 (2) ◽  
pp. 293-299 ◽  
Author(s):  
Sara M. Tolaney ◽  
Joon Jeong ◽  
Hao Guo ◽  
Jane Brock ◽  
Daniel Morganstern ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Hormone Receptor ◽  
Phase Ii Study ◽  
Hormone Receptor Positive ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document